Burkhard Hinz
Department of Experimental and Clinical Pharmacology and Toxicology
Friedrich Alexander University Erlangen-Nürnberg
Fahrstrasse 17
D-91054 Erlangen
Germany
Name/email consistency: high
- Dipyrone elicits substantial inhibition of peripheral cyclooxygenases in humans: new insights into the pharmacology of an old analgesic. Hinz, B., Cheremina, O., Bachmakov, J., Renner, B., Zolk, O., Fromm, M.F., Brune, K. FASEB J. (2007)
- Antipyretic analgesics: nonsteroidal antiinflammatory drugs, selective COX-2 inhibitors, paracetamol and pyrazolinones. Hinz, B., Brune, K. Handb. Exp. Pharmacol (2007)
- Bioavailability of diclofenac potassium at low doses. Hinz, B., Chevts, J., Renner, B., Wuttke, H., Rau, T., Schmidt, A., Szelenyi, I., Brune, K., Werner, U. Br. J. Clin. Pharmacol (2005)
- Latanoprost induces matrix metalloproteinase-1 expression in human nonpigmented ciliary epithelial cells through a cyclooxygenase-2-dependent mechanism. Hinz, B., Rösch, S., Ramer, R., Tamm, E.R., Brune, K. FASEB J. (2005)
- Pain and osteoarthritis: new drugs and mechanisms. Hinz, B., Brune, K. Curr. Opin. Rheumatol (2004)
- Up-regulation of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic death of human neuroglioma cells. Hinz, B., Ramer, R., Eichele, K., Weinzierl, U., Brune, K. Mol. Pharmacol. (2004)
- R(+)-methanandamide-induced cyclooxygenase-2 expression in H4 human neuroglioma cells: possible involvement of membrane lipid rafts. Hinz, B., Ramer, R., Eichele, K., Weinzierl, U., Brune, K. Biochem. Biophys. Res. Commun. (2004)
- 15-Deoxy-Delta(12,14)-prostaglandin J2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-gamma-independent mechanism. Hinz, B., Brune, K., Pahl, A. Biochem. Biophys. Res. Commun. (2003)
- Simultaneous determination of aceclofenac and three of its metabolites in human plasma by high-performance liquid chromatography. Hinz, B., Auge, D., Rau, T., Rietbrock, S., Brune, K., Werner, U. Biomed. Chromatogr. (2003)
- Aceclofenac spares cyclooxygenase 1 as a result of limited but sustained biotransformation to diclofenac. Hinz, B., Rau, T., Auge, D., Werner, U., Ramer, R., Rietbrock, S., Brune, K. Clin. Pharmacol. Ther. (2003)
- Cyclooxygenase-2--10 years later. Hinz, B., Brune, K. J. Pharmacol. Exp. Ther. (2002)
- Flurbiprofen enantiomers inhibit inducible nitric oxide synthase expression in RAW 264.7 macrophages. Hinz, B., Brune, K., Rau, T., Pahl, A. Pharm. Res. (2001)
- Nitric oxide inhibits inducible nitric oxide synthase mRNA expression in RAW 264.7 macrophages. Hinz, B., Brune, K., Pahl, A. Biochem. Biophys. Res. Commun. (2000)
- Prostaglandin E(2) upregulates cyclooxygenase-2 expression in lipopolysaccharide-stimulated RAW 264.7 macrophages. Hinz, B., Brune, K., Pahl, A. Biochem. Biophys. Res. Commun. (2000)
- Cyclooxygenase-2 expression in lipopolysaccharide-stimulated human monocytes is modulated by cyclic AMP, prostaglandin E(2), and nonsteroidal anti-inflammatory drugs. Hinz, B., Brune, K., Pahl, A. Biochem. Biophys. Res. Commun. (2000)
- Rapid non-genomic feedback effects of glucocorticoids on CRF-induced ACTH secretion in rats. Hinz, B., Hirschelmann, R. Pharm. Res. (2000)
- Dexamethasone megadoses stabilize rat liver lysosomal membranes by non-genomic and genomic effects. Hinz, B., Hirschelmann, R. Pharm. Res. (2000)
- New insights into physiological and pathophysiological functions of cyclo-oxygenase-2. Hinz, B., Brune, K. Curr. Opin. Anaesthesiol (2000)